Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensive Stage Small-cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01439568
What this trial is testing

LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma

Who this might be right for
Extensive Stage Small Cell Lung Carcinoma
Eli Lilly and Company 90
Early research (Phase 1)Study completedNCT05002868
What this trial is testing

Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors

Who this might be right for
Solid TumorExtensive-stage Small-cell Lung CancerLocally Advanced Breast Cancer+4 more
Rhizen Pharmaceuticals SA 23
Testing effectiveness (Phase 2)Study completedNCT00754858
What this trial is testing

Belotecan and Cisplatin in Treating Patients With Previously Untreated, Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Yonsei University 42
Early research (Phase 1)Looking for participantsNCT06598306
What this trial is testing

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Amgen 220
Large-scale testing (Phase 3)Study completedNCT04063163
What this trial is testing

A Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy in Patients With ES-SCLC

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Shanghai Henlius Biotech 585
Large-scale testing (Phase 3)Study completedNCT04712903
What this trial is testing

Durvalumab Plus Chemotherapy in Untreated Patients With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma Extensive Disease
AstraZeneca 101
Testing effectiveness (Phase 2)Looking for participantsNCT07803848
What this trial is testing

Study to Confirm Efficacy and Feasibility of Tarlatamab Treatment in Patients With Extensive Stage Small-cell Lung Cancer With Poor Performance Status

Who this might be right for
Small-cell Lung Cancer
AIO-Studien-gGmbH 57
Early research (Phase 1)Looking for participantsNCT07531095
What this trial is testing

Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)

Who this might be right for
Small Cell Lung Cancer
Amgen 160
Not applicableUnknownNCT00693836
What this trial is testing

Studying Patterns, Causes, and Control of Disease in Patients With Lung Cancer in the North Trent (England) Region

Who this might be right for
Lung Cancer
Cancer Research Centre at Weston Park Hospital 2,000
Testing effectiveness (Phase 2)Study completedNCT04462276
What this trial is testing

Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease

Who this might be right for
Small Cell Lung Cancer Extensive StageThoracic Radiotherapy
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 68
Testing effectiveness (Phase 2)Looking for participantsNCT07227597
What this trial is testing

A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Merck Sharp & Dohme LLC 170
Testing effectiveness (Phase 2)Ended earlyNCT01803269
What this trial is testing

Topotecan Hydrochloride or Cyclodextrin-Based Polymer-Camptothecin CRLX101 in Treating Patients With Recurrent Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer
University of Chicago 29
Early research (Phase 1)Study completedNCT00132054
What this trial is testing

Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Japan Multinational Trial Organization 30
Large-scale testing (Phase 3)UnknownNCT03711305
What this trial is testing

Study of Carboplatin Plus Etoposide With or Without SHR-1316 in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 462
Not applicableNot Yet RecruitingNCT07308379
What this trial is testing

Real-World Study of Toripalimab in Extensive-Stage Small Cell Lung Cancer

Who this might be right for
SCLC, Extensive StageToripalimab
Fudan University 1,200
Testing effectiveness (Phase 2)Active Not RecruitingNCT04397003
What this trial is testing

Personalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Washington University School of Medicine 6
Large-scale testing (Phase 3)Study completedNCT04005716
What this trial is testing

Study of Platinum Plus Etoposide With or Without Tislelizumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
BeiGene 457
Large-scale testing (Phase 3)Study completedNCT04028050
What this trial is testing

Atezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Hoffmann-La Roche 155
Testing effectiveness (Phase 2)UnknownNCT00014547
What this trial is testing

BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Lung Cancer
Theradex
Large-scale testing (Phase 3)UnknownNCT00519805
What this trial is testing

Dalteparin in Preventing Blood Clots in Patients With Lung Cancer

Who this might be right for
Lung CancerThromboembolism
Velindre NHS Trust 2,200
Next Page